CLINICAL_TRIALS trial_result · 2021-08-12

Clinical Trial Update: A Study of LY3127804 in Participants With COVID-19 [Phase 2]

Phase 2 clinical trial of LY3127804 in COVID-19 patients was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: COVID-19, Pneumonia | Phase 2 | Status: TERMINATED | Results posted: 2021-08-12